Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

OBJECTIVE: Deterioration in ventricular function is often observed in patients treated with anthracyclines for cancer. There is a paucity of evidence on interventions that might provide cardio-protection. We investigated whether prophylactic use of carvedilol can prevent doxorubicin-induced cardioto...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuosa, Ahmed Mohamed, Elshiekh, Ayman Hassan, Qureshi, Kahekashan, Abrar, Mohammed Burhan, Kholeif, Mona A., Kinsara, Abdulhalim Jamal, Andejani, Abdulwahab, Ahmed, Adel H., Cleland, John G.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical and Preventive Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310701/
https://www.ncbi.nlm.nih.gov/pubmed/30595329
http://dx.doi.org/10.1016/j.ihj.2018.06.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310701/
https://www.ncbi.nlm.nih.gov/pubmed/30595329
http://dx.doi.org/10.1016/j.ihj.2018.06.011

Ejemplares similares